T13 · Trade opportunity evidence

China (CHN) to MDV (MDV) medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale (HS6 300490)

A country-to-country view of reported medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale trade, combining buyer demand, exporter position, market structure, access conditions, and observed lane history.

Exporter China (CHN)Importer MDV (MDV)HS6 300490Two-way vertical tradeCoverage 2004-2024Growing

3-year buyer projection

$46.9MCalculated from reported demand

Exporter growth

+9.8%Full available history

Suppliers in market

51Latest reported count

Observed history

21 yearsLast year: 2024

Reported observations

What this medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale lane shows for HS 300490

Core values for China (CHN) → MDV (MDV) in HS 300490.

Buyer market

Latest imports$34.6M
Five-year projection$57.4M
Buyer CAGR+10.7%
Latest annual change-4.6%

Exporter position

Latest exports$96.1K
Market share0.3%
Share change+0.2 pp
Best observed share55.2%

Market structure

Reported suppliers51
Concentration index3,206.8
Share gap+54.9 pp
SignalGrowing

Detailed evidence

Complete lane evidence

Reported values, calculated indicators, and country-pair context for this route.

MeasureValueWhat it describes
Buyer imports$34.6MMDV (MDV)'s latest reported imports
Exporter exports$96.1KChina (CHN)'s exports to MDV (MDV)
Exporter market share0.3%Exporter share of the reported buyer market
Buyer five-year CAGR+10.7%Annualized change in buyer imports
Exporter full-history CAGR+9.8%Annualized change in exporter exports
Three-year buyer projection$46.9MCalculated projection from reported demand
Five-year buyer projection$57.4MCalculated projection from reported demand
Average buyer imports$11.8MAverage reported importer value
Peak buyer imports$36.2MHighest reported importer value
Average exporter exports$33.7KAverage reported lane exports
Peak exporter exports$139.2KHighest reported lane exports
Share change+0.2 ppLatest one-year change in exporter share
Reported suppliers51Supplier countries observed in the latest period
Buyer GDP$4.9BLatest buyer-country GDP estimate
Buyer GDP per person$9.0KLatest buyer-country GDP per person
Buyer population543.6 thousandLatest buyer-country population estimate
Buyer investment rate29.4%Reported buyer-country investment rate
Buyer secondary education66.5%Reported secondary education coverage
Distance5,862 kmApproximate country-pair distance
Business entry time12 daysReported days to start a business
Shared legal systemNoCountry-pair institutional relationship
Reported FTANoReported trade-agreement indicator
WTO memberYesBuyer-country WTO membership indicator
Lane volatility1.2Variation indicator across observed lane values
Maximum drawdown98.6%Largest observed decline from a prior peak
Observed history21 yearsCoverage through 2024

Research reading

Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale demand and the China (CHN) to MDV (MDV) lane

MDV (MDV) reported $34.6M of medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale imports in 2024. China (CHN) accounted for 0.3% of the observed market and reported $96.1K in exports on this lane.

The latest annual values eased slightly, while the longer available history shows +10.7% buyer growth and +9.8% exporter growth. The page separates reported values from projections and indicators.

Product classification

What does HS 300490 include?

HS 300490 covers Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale. This page studies the six-digit Harmonized System classification rather than a company, brand, retail category, or individual shipment.

The classification sits in HS chapter 30 and heading 3004. The recorded trade type is two-way vertical trade, with a high price range classification in the available product reference data.

How to interpret this page

Compare demand, position, and history together

This HS 300490 trade opportunity page brings together the buyer market in MDV (MDV), the exporter position of China (CHN), and the observed conditions of their trade lane. A large buyer market does not by itself show that every exporter has equal access, and a positive growth rate does not remove the need to examine volatility and historical coverage.

Use the reported imports and exports to understand scale, market share to understand position, projections to understand the calculated forward view, and lane history to understand how much evidence supports the comparison.

Frequently asked questions

Questions about China (CHN) to MDV (MDV) medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale trade

What is the HS code for this product?

This page covers HS 300490, the six-digit product classification shown in the trade records.

How large is the MDV (MDV) market?

The page reports the latest buyer imports, historical averages, peaks, growth, and calculated projections for medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale.

How strong is China (CHN) in this market?

Exporter performance is shown through lane exports, market share, share change, growth, and the number of reported suppliers.

What should be checked before entering this market?

Review market scale, competition, access indicators, volatility, drawdown, and the available history together rather than relying on one signal.

Definitions and coverage

How to read this page

Reported values

Trade values describe reported merchandise trade for the stated HS6 classification. They are not company-level sales or shipment records.

Calculated indicators

Growth, projections, concentration, volatility, and share-gap figures are calculated from the reported observations and should be interpreted with their coverage period.

Coverage

This sample covers 21 observed years through 2024. Missing values are shown as not reported rather than estimated.